GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Auxilium Pharmaceuticals, Inc. (AUXL) [hlAlert]

Rating:
Buy AUXL
up 63.91 %

Auxilium Pharmaceuticals, Inc. (AUXL) rated Buy with price target $28 by Stanford Research

Posted on: Friday,  Nov 14, 2008  8:25 AM ET by Stanford Research

Stanford Research rated Buy Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) on 11/14/2008, when the stock price was $22.25. Since
then, Auxilium Pharmaceuticals, Inc. has gained 63.91% as of 01/29/2015's recent price of $36.47.
If you would have followed this Stanford Research's recommendation on AUXL, you would have gained 63.91% of your investment in 2267 days.

Auxilium Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and markets products for urology and sexual health. Auxilium markets Testim 1%, a topical testosterone gel, for the treatment of hypogonadism. Auxilium is developing additional Testim line extensions, as well as other products for urology and sexual health, including an enzyme in Phase II for the treatment of Peyronie's Disease that may also prove useful for the treatment of Dupuytren's Disease.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/14/2008 8:25 AM Buy
None
22.25 28.00
as of 12/24/2008
1 Week down  -0.44 %
1 Month down  -13.35 %
3 Months down  -14.02 %
1 YTD down  -14.02 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy